Medical Equipment

Lyme Disease Testing Market Insights Report: Opportunities and Drivers 2030

February 6, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Lyme Disease Testing Market between 2026 and 2030?

The lyme disease testing market has demonstrated robust growth in its size over recent years. It is projected to expand from $10.68 billion in 2025 to $11.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. This expansion during the preceding period can be attributed to factors such as an increasing occurrence of lyme disease, insufficient public knowledge about early detection, the continued use of conventional serological testing, a rise in hospital-based diagnostic services, and expanding research initiatives focused on tick-borne diseases.

Significant expansion is anticipated for the lyme disease testing market in the coming years. By 2030, this market is projected to reach $16.46 billion, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is propelled by factors such as the implementation of AI-assisted diagnostic tools, the rise in popularity of home-testing kits, the development of multi-disease panels, augmented government funding for surveillance of tick-borne diseases, and the incorporation of cloud-based laboratory data management systems. Key developments expected in this period encompass the broadening of point-of-care testing, the emergence of home-based lyme disease diagnostic solutions, the use of multi-pathogen tick-borne panels, wider acceptance of rapid test kits, and the creation of personalized diagnostic protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp

Which Drivers Are Expected To Impact The Lyme Disease Testing Market During The Forecast Period?

The increasing occurrence of tick-borne diseases is anticipated to drive the expansion of the lyme disease testing market in the future. These illnesses represent a category of conditions transmitted to people by the bite of infected ticks, which are tiny, blood-feeding parasites present in grassy, wooded, or rural environments. The escalating need for treatments for tick-borne ailments is further exacerbated by the widening geographical spread of ticks, a consequence of climate change, resulting in increased human exposure and infection rates. As the main method of transmitting Lyme disease, tick-borne illnesses significantly contribute to the need for Lyme disease testing, making early detection and diagnosis essential for effectively managing the growing number of infection cases. For example, the U.S. Centers for Disease Control and Prevention (CDC), a U.S.-based federal public health agency, reported in March 2025 that over 89,000 cases of Lyme disease occurred in 2023, signifying an ongoing substantial impact of tick-borne illnesses relative to prior years. Consequently, the growing prevalence of tick-borne diseases is propelling the expansion of the lyme disease testing market.

Which Segments Are Driving Activity In The Lyme Disease Testing Market?

The lyme disease testing market covered in this report is segmented –

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

What Trends Are Reshaping The Dynamics Of The Lyme Disease Testing Market?

Major companies operating in the Lyme disease testing market are prioritizing technological advancements in diagnostic tools to improve test accuracy, reduce turnaround times, and allow for earlier detection of the disease. Diagnostic tools refer to medical devices, kits, or technologies utilized to identify the presence of Lyme disease by pinpointing specific antibodies, antigens, or genetic material associated with the Borrelia burgdorferi bacteria. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, announced the release of a state-of-the-art Lyme Disease Diagnostic Kit. This kit is an ELISA-based assay developed using their proprietary EpitoGen platform. It features approximately 120 distinct Borrelia epitopes, ensuring high specificity and sensitivity, and is specifically designed for research use (RUO). The kit supports early, strain-specific detection and can be customized for various laboratory applications. Intended for research and diagnostic labs, it is ideal for boosting detection accuracy and enabling deeper insights into Lyme disease.

Which Major Firms Are Strengthening Their Position In The Lyme Disease Testing Market?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Hologic Inc., Seegene Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Lyme Disease Testing Market?

North America was the largest region in the lyme disease testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lyme Disease Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25817&type=smp

Browse Through More Reports Similar to the Global Lyme Disease Testing Market 2026, By The Business Research Company

Biologics Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Covid 19 Saliva Screening Test Potential Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Typhoid Antibody Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795